Choksi Laboratories Share Price

Small Cap | Pharmaceuticals and health care | BSE: 526546

₹113.00 image-5.90 (-4.96 %)

Last Updated: 07 Apr 2025 04:01 PM

Technicalsimage BEARISHimage

Overview

Open (₹) 113.00

High (₹) 113.00

Low (₹) 113.00

Prev. Close (₹) 118.90

Volume 1,622

VWAP (₹) 119.35

ROCE (%) 10.83

Industry P/E 59.42

TTM P/E 61.41

P/B Ratio 3.54

Market Cap (₹) Cr.78.71

Dividend Yield (%)--

EPS (₹) 1.59

ROE4.99%

Sales Growth (%) 6.55

Profit Growth (%)-65.43

Day Range

113.00113.00

L
H

52 Week Range

48.25142.40

L
H

Historical Returns

Returns (6M)

62.29 %

Returns (1Y)

112.01 %

Returns (3Y)

314.68 %

Returns (5Y)

1173.96 %

Returns (6M)

62.29 %

Returns (1Y)

112.01 %

Returns (3Y)

314.68 %

Returns (5Y)

1173.96 %

SWOT Analysis

  • Growth in Net Profit Margin (QoQ)
  • Strong long-term momentum: Price above long-term moving averages (EMA_200)
  • Price above EMA and SMA (50) indicates bullish momentum.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bearish
Bullish

RSI 48.22

MFI 64.78

ATR 3.21

Commodity Channel Index -204.18

ROC125 55.48

ROC21 -4.60

Williams %R -100.00

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current119.70120.30120.60119.40118.80118.50117.90
Week Ago130.70132.40133.30129.80128.10127.20125.50
Month Ago118.90121.56125.01115.45112.79109.34106.68

EMA & SMA
info_icon

113.00

Current Price

EMA & SMApin

Bullish Moving Averages

6

Bearish Moving Averages

14

5 Day 125.67


9 Day 129.08


10 Day 130.13


12 Day 131.87


14 Day 131.79

20 Day 133.22


26 Day 128.31


50 Day 110.90


100 Day 88.56


200 Day 77.25

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
PARDEEP KUMAR AGGARWAL HUFbulkSell18 Mar, 2025₹129.961,02,201BSE
SANJAY AGARWALbulkBuy18 Mar, 2025₹129.9540,000BSE
PARDEEP KUMAR AGGARWAL HUFbulkBuy18 Mar, 2025₹125.0015BSE
ANITA AGARWALbulkBuy18 Mar, 2025₹129.9440,000BSE
NEXUS GLOBAL OPPORTUNITIES FUNDbulkBuy27 Feb, 2025₹121.5035,000BSE
EMKAY COMMERCIAL COMPANY LIMITEDbulkBuy18 Feb, 2025₹132.6569,000BSE
ASC CONSULTING PRIVATE LIMITEDbulkBuy18 Feb, 2025₹132.5162,000BSE
DHEERAJ KUMAR LOHIAbulkSell11 Feb, 2025₹136.8541,222BSE
EMKAY COMMERCIAL COMPANY LIMITEDbulkBuy11 Feb, 2025₹137.1791,000BSE
CSG FINANCIAL & MANAGEMENT SERVICES PRIVATE LIMITEDbulkSell27 Jan, 2025₹110.5842,583BSE

Insider Trading

No insider trading details available.

Corporate Actions

No corporate actions available.

Announcements

DateSourceDetail
07 Apr, 2025BSE IndiaPursuant to Regulation 74(5) of SEBI (DP) Regulation, 2018 attached herewith the certificate issued by RTA of the company
14 Feb, 2025BSE IndiaIntegrated Financials for the quarter and nine month ended 31st December, 2024
14 Feb, 2025BSE IndiaConsidered and approved unaudited financial results for the quarter and nine month ended 31st December, 2025
14 Feb, 2025BSE India1. Considered and approved Unaudited Financial Results for the Quarter and Nine Month ended 31st December, 2024 along with the Limited review report;\r\n2. Other routine businesses with the permission of Chair\r\n
05 Feb, 2025BSE IndiaCHOKSI LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve 1. To consider and approve the Un-Audited Financial Results of the Company for the quarter as well as nine months ended on 31st December, 2024 along with the Limited Review Report thereon;\r\n2. Any other item may be taken up for consideration with the permission of the Chairman and with the consent of a majority of the Directors present in the Meeting, which shall include at least one independent Director. If any.
07 Jan, 2025BSE IndiaPursuant to Regulation 74(5) of SEBI (DP) Regulations, 2018 attached herewith the certificate issued by RTA of the company for the quarter ended 31.12.2024
03 Jan, 2025BSE IndiaIntimation regarding change in name of RTA of the company is attached herewith
03 Jan, 2025BSE IndiaThe clarification is attached herewith
03 Jan, 2025BSE IndiaThe Exchange has sought clarification from Choksi Laboratories Ltd on January 3, 2025, with reference to Movement in Price.<BR><BR>The reply is awaited.
14 Nov, 2024BSE IndiaConsidered and approved Unaudited Financial Results along with Limited review report for the quarter and half year ended 30th September,2024

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--06 Feb, 202514 Feb, 2025
Quarterly Results--06 Nov, 202414 Nov, 2024
Quarterly Results--06 Aug, 202413 Aug, 2024
Audited Results--22 May, 202429 May, 2024
OthersTo consider, reviews and finalize the matters to be included in the Postal Ballot Notice, E-voting period and other matters pursuant to which.23 Mar, 202427 Mar, 2024
Quarterly Results--30 Jan, 202403 Feb, 2024
Quarterly Results--06 Nov, 202310 Nov, 2023
Quarterly Results & A.G.M.--07 Aug, 202312 Aug, 2023
Others--04 Jul, 202305 Jul, 2023
Audited Results--24 May, 202329 May, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Dec, 2023Dec, 2022Dec, 2021Dec, 2020
Promoter Group31.48%31.48%31.48%31.48%31.48%
Foreign Institutions +0%0%0%0%0%
Domestic Institutions +0%0%0%0%0%
Government0%0%0%0%0%
Public68.52%68.52%68.52%68.52%68.52%
Others0%0%0%0%0%

About Choksi Laboratories

Choksi Laboratories is a Public Limited Listed company incorporated on 29/01/1993 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L85195MP1993PLC007471 and registration number is 007471. Currently company belongs to the Industry of Medical Research Services. Company’s Total Operating Revenue is Rs. 36.70 Cr. and Equity Capital is Rs. 6.97 Cr. for the Year ended 31/03/2024.

Parent Organisation

Not Applicable

Founded

1993

Managing Director

Mr. Sunil Kumar Choksi

NSE Symbol

--

Choksi Laboratories Management

NameDesignation
Mr. Sunil Kumar ChoksiManaging Director
Mrs. Stela ChoksiWhole Time Director
Ms. Himika ChoksiWhole Time Director
Mr. Vyangesh ChoksiWhole Time Director
Mr. Raghmendra SinghIndependent Director
Mrs. Meenaxi PatidarIndependent Director
Mrs. Prachi MantriIndependent Director
Mrs. Abha ShastriIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Syngene International₹28,060.85₹697.10 image
₹724.65(-3.80%)
₹608.000 - ₹960.000
Sun Pharma Advanced Research Company₹4,627.03₹142.58 image
₹145.54(-2.03%)
₹109.200 - ₹474.000
Suven Life Sciences₹2,590.93₹118.81 image
₹128.72(-7.70%)
₹83.270 - ₹169.000
Vimta Labs₹1,923.40₹865.05 image
₹924.45(-6.43%)
₹420.000 - ₹1,183.000
Choksi Laboratories₹78.71₹113.00 image
₹118.90(-4.96%)
₹46.510 - ₹142.400

FAQs on Choksi Laboratories

What is the share price of Choksi Laboratories?

The share price of Choksi Laboratories on 07 Apr, 2025 is ₹ 113.00.

What is 52W high and 52W low share price of Choksi Laboratories?

The highest and lowest 52W share prices of Choksi Laboratories are ₹ 142.400 and ₹ 46.510

What is the market cap of Choksi Laboratories?

The market capitalization of Choksi Laboratories as of 07 Apr, 2025 is ₹ 78.71 Crores

What is the P/E ratio of Choksi Laboratories?

The current P/E ratio of Choksi Laboratories as of 07 Apr, 2025 is 59.42

What is the PB ratio of Choksi Laboratories?

The PB ratio of Choksi Laboratories as of 07 Apr, 2025 is 3.54

Top Gainers

₹67.00image

₹56.11 (0.19%)

₹64.50image

₹55.00 (0.17%)

₹33.41image

₹27.96 (0.19%)

Top Losers

₹20.60image

₹24.76 (-0.17%)

₹6.40image

₹7.52 (-0.15%)

₹2,814.65image

₹4,939.80 (-0.43%)

₹75.12image

₹89.69 (-0.16%)

Market Indices

Sensex

₹73,137.90image

₹75,364.69 (-0.03%)

Source : Dion Global Solutions Limited